The store will not work correctly when cookies are disabled.
4-(2-(benzylthio)ethyl)-3-phenyl-1H-1,2,4-triazole-5(4H)-thione
ID: ALA5091922
PubChem CID: 146562891
Max Phase: Preclinical
Molecular Formula: C17H17N3S2
Molecular Weight: 327.48
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: S=c1[nH]nc(-c2ccccc2)n1CCSCc1ccccc1
Standard InChI: InChI=1S/C17H17N3S2/c21-17-19-18-16(15-9-5-2-6-10-15)20(17)11-12-22-13-14-7-3-1-4-8-14/h1-10H,11-13H2,(H,19,21)
Standard InChI Key: ATHVVQOOZYRQFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
2.5886 -14.0104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2741 -14.4552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9103 -13.9421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6166 -13.1768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8016 -13.2227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2869 -12.5925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5807 -11.8287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0667 -11.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2587 -11.3227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9675 -12.0907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4834 -12.7217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6994 -14.1544 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.0604 -12.4906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8765 -12.5318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3203 -11.8456 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.1364 -11.8869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5802 -11.2007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3938 -11.2459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8374 -10.5606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4650 -9.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6445 -9.7933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2045 -10.4795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 6 1 0
3 12 2 0
4 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.48 | Molecular Weight (Monoisotopic): 327.0864 | AlogP: 4.54 | #Rotatable Bonds: 6 |
Polar Surface Area: 33.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.74 | CX Basic pKa: ┄ | CX LogP: 4.82 | CX LogD: 4.67 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.53 | Np Likeness Score: -2.00 |
References
1. Legru A, Verdirosa F, Hernandez JF, Tassone G, Sannio F, Benvenuti M, Conde PA, Bossis G, Thomas CA, Crowder MW, Dillenberger M, Becker K, Pozzi C, Mangani S, Docquier JD, Gavara L.. (2021) 1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity., 226 [PMID:34626878] [10.1016/j.ejmech.2021.113873] |